Our Science

The Center for Cancer Research (CCR) is part of the National Cancer Institute (NCI). Our mission is to inform and empower the entire cancer research community by making breakthrough discoveries in basic and clinical cancer research and by developing these discoveries into new therapeutic interventions for adults and children afflicted with cancer or infected with HIV.

To learn more about our new research initiatives and programs, visit these sections of our Web site:

Women Scientist Advisors (WSA) — Supporting the development and retention of our women scientists

Research Directory

CCR’s online Research Directory highlights the research accomplishments of CCR’s investigators and provides an overview of our branches, laboratories, and programs.

Centers of Excellence

The NCI Intramural Research Program (IRP) has established four Centers of Excellence that provide centralized resources and infrastructure aimed at accelerating the discovery, development, and delivery of interventions for preventing, diagnosing, and treating cancer and HIV/AIDS:
Chromosome Biology
HIV/AIDS & Cancer Virology
Immunology
Integrative Cancer Biology and Genomics

Initiatives

The Division of Cancer Treatment and Diagnosis (DCTD) is working in close collaboration with CCR to reinvigorate cancer drug development at NCI. The NCI Experimental Therapeutics (NExT) Program combines the DCTD’s expertise in anticancer drug development with CCR’s dynamic in-house research program and our state-of-the-art facilities at the NIH Clinical Center.

The goal of the NExT Program is to shave up to 1 year off the typical drug 10- to 12-year drug development cycle. MORE . . .
CCR led the way in establishing the NIH Chronic Graft vs. Host Disease Consortium, a forum for interaction among all NIH investigators interested in studying this disease. MORE . . .